Diagnostics & Research
The Diagnostics & Research industry has a total of 49 stocks, with a combined market cap of $724.8 billion, total revenue of $169.25 billion and a weighted average PE ratio of 43.29.
Market Cap
724.8B
Revenue
169.25B
Profits
16.74B
PE Ratio
43.29
Profit Margin
9.89%
Dividend Yield
0.22%
49 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 192.05B | 0.05% | 63,117 | 44.56B |
| 2 | DHR | Danaher Corporation | 148.12B | 0.01% | 78,673 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 50.31B | -0.87% | 16,909 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 34.68B | -0.22% | 37,607 | 6.95B |
| 5 | WAT | Waters Corporation | 32.75B | 0.18% | 17,531 | 3.17B |
| 6 | NTRA | Natera, Inc. | 29.35B | 0.04% | 15,969 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 28.00B | - | 1,509 | 4.03B |
| 8 | IQV | IQVIA Holdings Inc. | 27.93B | -0.64% | 37,087 | 16.31B |
| 9 | LH | Labcorp Holdings Inc. | 23.30B | 0.28% | 32,379 | 13.95B |
| 10 | DGX | Quest Diagnostics Incorporated | 22.30B | 0.16% | 12,517 | 11.04B |
| 11 | EXAS | Exact Sciences Corporation | 19.77B | 0.15% | 57,470 | 3.25B |
| 12 | ILMN | Illumina, Inc. | 17.79B | -1.10% | 66,317 | 4.34B |
| 13 | GH | Guardant Health, Inc. | 13.27B | -1.85% | 68,952 | 982.02M |
| 14 | MEDP | Medpace Holdings, Inc. | 12.85B | -0.19% | 6,332 | 2.53B |
| 15 | RVTY | Revvity, Inc. | 11.37B | -0.08% | 11,344 | 2.86B |
| 16 | QGEN | Qiagen N.V. | 9.86B | -1.48% | 58,182 | 2.09B |
| 17 | CRL | Charles River Laboratories International, Inc. | 8.21B | -1.30% | 9,907 | 4.02B |
| 18 | ICLR | ICON Public Limited Company | 7.85B | 3.07% | 94,391 | 8.10B |
| 19 | RDNT | RadNet, Inc. | 5.38B | -0.90% | 4,123 | 1.97B |
| 20 | SHC | Sotera Health Company | 4.98B | 0.29% | 6,245 | 1.15B |
| 21 | BLLN | BillionToOne, Inc. | 3.89B | -0.48% | 8,469 | 254.14M |
| 22 | TWST | Twist Bioscience Corporation | 2.87B | -3.58% | 74,557 | 391.56M |
| 23 | VCYT | Veracyte, Inc. | 2.81B | -0.07% | 22,210 | 495.14M |
| 24 | NEOG | Neogen Corporation | 2.46B | - | 31,433 | 880.32M |
| 25 | WGS | GeneDx Holdings Corp. | 2.39B | 0.57% | 75,211 | 427.54M |
| 26 | GRAL | GRAIL, Inc. | 1.83B | -9.76% | 631,935 | 147.17M |
| 27 | NEO | NeoGenomics, Inc. | 1.28B | - | 89,084 | 727.33M |
| 28 | CDNA | CareDx, Inc. | 969.51M | 0.27% | 15,048 | 358.00M |
| 29 | OPK | OPKO Health, Inc. | 917.40M | -0.42% | 36,612 | 642.07M |
| 30 | CSTL | Castle Biosciences, Inc. | 846.47M | -0.72% | 14,470 | 343.53M |
| 31 | FLGT | Fulgent Genetics, Inc. | 716.55M | - | 6,110 | 315.55M |
| 32 | PSNL | Personalis, Inc. | 702.44M | -4.47% | 45,089 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 396.16M | -0.93% | 20,313 | 825.30M |
| 34 | BNR | Burning Rock Biotech Limited | 312.34M | - | 621 | 75.75M |
| 35 | PRE | Prenetics Global Limited | 279.35M | -2.64% | 38,873 | 92.39M |
| 36 | MDXH | MDxHealth SA | 186.45M | - | 4,662 | 103.07M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 176.59M | - | 1,930 | 4.40M |
| 38 | FONR | FONAR Corporation | 121.90M | -0.03% | 613 | 106.03M |
| 39 | BDSX | Biodesix, Inc. | 107.40M | 2.35% | 8,692 | 80.17M |
| 40 | XGN | Exagen Inc. | 77.28M | - | 9,464 | 63.60M |
| 41 | PRPO | Precipio, Inc. | 43.41M | -2.29% | 254 | 22.80M |
| 42 | MBAI | Check-Cap Ltd. | 11.81M | -1.82% | 7,085 | - |
| 43 | NOTV | Inotiv, Inc. | 9.46M | 5.36% | 18,028 | 514.03M |
| 44 | MYNZ | Mainz Biomed N.V. | 6.58M | - | 15,289 | 659.94K |
| 45 | ADVB | Advanced Biomed Inc. | 5.58M | 2.23% | 10,188 | - |
| 46 | BIAF | bioAffinity Technologies, Inc. | 4.81M | -0.93% | 7,369 | 6.78M |
| 47 | NDRA | ENDRA Life Sciences Inc. | 4.43M | -3.80% | 6,257 | - |
| 48 | ISPC | iSpecimen Inc. | 2.44M | -10.42% | 217,519 | 3.35M |
| 49 | XWEL | XWELL, Inc. | 2.16M | -1.26% | 3,656 | 29.52M |